By Counterforce Health Team in Xospata (gilteritinib) —

Lowering Out-of-Pocket for Xospata (gilteritinib) with Aetna (CVS Health) in Pennsylvania: Copay, Tiering & Assistance

Answer Box: Getting Xospata (gilteritinib) Covered by Aetna (CVS Health) in Pennsylvania

Xospata requires prior authorization from Aetna (CVS Health) with documented FLT3 mutation testing and relapsed/refractory AML diagnosis. The medication costs approximately $28,979 per 30-day supply but copay assistance can reduce costs to $0 for commercially insured patients. First step: Have your oncologist submit a complete prior authorization package including FLT3 test results, medical necessity letter, and prior treatment history through Aetna's provider portal. If denied, Pennsylvania's new external review program has overturned 53% of appeals in 2024.

Table of Contents

What Drives Xospata Costs

Understanding your Aetna (CVS Health) plan's benefit design helps you navigate Xospata's high cost structure. At a wholesale acquisition cost of $28,979.13 for a 30-day supply, Xospata sits on specialty drug tiers that typically require higher cost-sharing.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Must get approval before coverage Aetna Precertification List
Specialty Tier Higher copay/coinsurance Your plan documents Aetna Specialty Drug List
Quantity Limit 90 tablets per 30 days Plan formulary CVS Specialty
Step Therapy May require trying alternatives first PA criteria Aetna Provider Portal

Key factors affecting your out-of-pocket costs:

  • Formulary tier placement: Xospata typically sits on Tier 4 or 5 (specialty), meaning 20-40% coinsurance rather than fixed copays
  • Deductible status: You may pay full cost until meeting your specialty drug deductible
  • Annual out-of-pocket maximum: Once reached, Aetna covers 100% for the rest of the year

Benefit Investigation: What to Ask

Before starting treatment, gather specific information about your Xospata coverage. Contact Aetna member services using the number on your insurance card and ask:

Essential Questions Checklist

Coverage Details:

  • "What is my copay or coinsurance for Xospata (NDC 59148-001-90)?"
  • "Do I have a separate specialty drug deductible?"
  • "What's my annual out-of-pocket maximum for specialty drugs?"

Prior Authorization:

  • "Is prior authorization required for Xospata?"
  • "What documentation does my doctor need to submit?"
  • "How long does PA review typically take?"

Pharmacy Requirements:

  • "Must I use CVS Specialty Pharmacy for Xospata?"
  • "Can I get 90-day supplies?"
Tip: Record the representative's name, date, and reference number for your call. This documentation helps if you need to reference the conversation later.

Assistance Options

Multiple programs can significantly reduce your Xospata costs, depending on your insurance type and financial situation.

Manufacturer Copay Assistance

Astellas Xospata Patient Savings Program offers the most substantial savings for eligible patients:

  • Benefit: Pay as little as $0 per prescription
  • Eligibility: Commercial insurance (not Medicare, Medicaid, or TRICARE)
  • How to enroll: Visit Xospata.com/support/patient-assistance or call the support line
  • Duration: Typically valid for 12 months, renewable

Foundation Grants

For patients with government insurance or those who don't qualify for copay cards, independent foundations provide grants:

Patient Access Network (PAN) Foundation

  • Covers AML treatments including Xospata
  • Income limits typically 500% of federal poverty level
  • Apply at panfoundation.org

Leukemia & Lymphoma Society

  • Co-Pay Assistance Program for blood cancer patients
  • Up to $5,000 annually for eligible treatments
  • Apply at lls.org/copay-assistance
Note: Foundation funding availability changes throughout the year. Apply early and check back if initially unavailable.

Hospital Financial Assistance

Many Pennsylvania hospitals offer charity care or payment plans. Ask your cancer center's financial counselor about:

  • Sliding scale discounts based on income
  • Interest-free payment plans
  • Emergency hardship funds

Tiering Exceptions

If Xospata isn't on your plan's formulary or sits on a high-cost tier, you can request a tiering exception through Aetna's formulary exception process.

When to Request an Exception

Strong cases include:

  • All preferred alternatives contraindicated or failed
  • Documented severe side effects from formulary drugs
  • Unique clinical circumstances requiring Xospata specifically

Documentation Needed

Your oncologist should submit:

  1. Medical necessity letter explaining why Xospata is essential
  2. Prior treatment history with dates, drugs tried, and outcomes
  3. Clinical notes showing disease progression or intolerance
  4. Peer-reviewed literature supporting Xospata use in your situation
Clinician Corner: Medical necessity letters should reference FDA labeling, NCCN guidelines, and specific clinical factors like FLT3 mutation subtype, prior therapy failures, and contraindications to alternatives. Include monitoring plans and treatment goals.

Pharmacy Choice & Coordination

Aetna requires Xospata dispensing through CVS Specialty Pharmacy, which affects both cost and convenience.

CVS Specialty Requirements

  • No retail pickup: Xospata ships via mail only
  • Coordination needed: CVS Specialty coordinates with your oncology team
  • Refill timing: Order 7-10 days before running out
  • Storage: Requires room temperature storage; plan for delivery timing

Cost Optimization Tips

Work with CVS Specialty to:

  • Apply manufacturer copay cards before first fill
  • Coordinate foundation grants if eligible
  • Set up automatic refills to avoid gaps
  • Request 90-day supplies when possible (reduces per-fill fees)

If you're traveling or have delivery concerns:

  • CVS Specialty can ship to temporary addresses
  • Expedited shipping available for urgent needs
  • Coordinate with your oncology team for treatment schedule alignment

Appeals on Cost Grounds

When Aetna denies coverage or places Xospata on an unaffordable tier, Pennsylvania patients have strong appeal rights.

Pennsylvania's External Review Success

Since January 2024, Pennsylvania's Independent External Review Program has overturned 53% of appealed denials, giving patients a powerful tool for expensive specialty drugs.

Appeal Timeline

Internal Appeal (Required First):

  1. Submit within 180 days of denial
  2. Aetna has 30 days for standard review (72 hours if expedited)
  3. Gather additional clinical documentation

External Review (If Internal Appeal Fails):

  1. File with Pennsylvania Insurance Department within 4 months
  2. Standard review: 45 days for decision
  3. Expedited review: 72 hours for urgent cases

Strengthening Your Appeal

Cost-based arguments that work:

  • Document financial hardship from high cost-sharing
  • Show Xospata is the most cost-effective option long-term
  • Provide evidence that alternatives are more expensive when accounting for monitoring, side effects, or treatment failures

Medical necessity reinforcement:

  • Updated disease status showing need for continued treatment
  • Literature showing Xospata's unique mechanism for your FLT3 mutation type
  • Oncologist attestation that no suitable alternatives exist

Renewal Budgeting

Xospata costs can change annually, so plan ahead for benefit year transitions.

What Changes Each Year

January 1st resets:

  • Deductibles restart (you pay full cost until met)
  • Out-of-pocket maximums reset
  • Formulary placement may change

Mid-year changes possible:

  • Prior authorization criteria updates
  • Tier placement modifications
  • Copay assistance program renewals

Planning Strategies

Before your plan year ends:

  • Maximize current year benefits if close to out-of-pocket max
  • Renew manufacturer copay assistance programs
  • Reapply for foundation grants

For the new year:

  • Budget for full deductible payment initially
  • Confirm Xospata remains covered
  • Update copay assistance enrollment
From our advocates: One patient saved over $15,000 by timing their Xospata refills strategically around their plan year. They filled a 90-day supply in December after meeting their out-of-pocket maximum, then immediately applied for renewed copay assistance for January. This composite example shows how proactive planning reduces costs significantly.

Conversation Scripts

Calling Aetna Member Services

"Hi, I'm calling about coverage for Xospata, generic name gilteritinib, for my acute myeloid leukemia treatment. My member ID is [number]. I need to understand:

  • My exact copay or coinsurance for this medication
  • Whether prior authorization is required and what my doctor needs to submit
  • If I must use CVS Specialty Pharmacy
  • My current deductible status for specialty drugs

Can you also confirm my annual out-of-pocket maximum and how much I've already met this year?"

Requesting Peer-to-Peer Review

"This is [clinic name] calling to request a peer-to-peer review for our patient's Xospata prior authorization denial. The member ID is [number]. Our oncologist needs to speak with your medical director about the clinical necessity for gilteritinib in this relapsed FLT3-mutated AML case. When can we schedule this review?"

CVS Specialty Coordination

"I'm calling about my Xospata prescription. I have manufacturer copay assistance and want to ensure it's applied correctly. Can you:

  • Confirm my copay card is active in your system
  • Tell me my exact out-of-pocket cost for the next refill
  • Set up automatic refills so I don't run out
  • Provide tracking information for my current shipment"

FAQ

How long does Aetna prior authorization take for Xospata in Pennsylvania? Standard PA decisions are made within 24-48 hours for over 95% of requests, according to Aetna's public commitments. Expedited reviews for urgent cases are completed within 72 hours.

What if Xospata is non-formulary on my Aetna plan? You can request a formulary exception by having your oncologist submit medical necessity documentation. The process is similar to prior authorization but requires stronger justification for why formulary alternatives won't work.

Can I request an expedited appeal in Pennsylvania? Yes, if delay would seriously threaten your health. Both Aetna internal appeals and Pennsylvania external reviews offer expedited processes with 72-hour decision timelines.

Does step therapy apply if I've already failed other treatments? Document all prior FLT3 inhibitor failures or intolerances. Step therapy requirements are waived when you provide evidence of previous treatment attempts, even if they occurred outside Pennsylvania.

How do I know if I qualify for manufacturer copay assistance? The Xospata Patient Savings Program is available to patients with commercial insurance (not Medicare, Medicaid, or TRICARE). Check eligibility online or call their support line directly.

What happens if I can't afford Xospata even with assistance programs? Contact your hospital's financial counselor about charity care programs, payment plans, or emergency hardship funds. Some Pennsylvania cancer centers have specific funds for expensive specialty medications.

About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by creating targeted, evidence-backed rebuttal letters. The platform analyzes denial reasons and drafts point-by-point responses aligned with each payer's specific policies and requirements.

When navigating Xospata coverage challenges with Aetna, having professional appeal support can make the difference between paying full price and getting your treatment covered. Counterforce Health's specialized approach to prior authorization and appeals has helped numerous patients access expensive specialty medications through strategic documentation and policy-based arguments.

Sources & Further Reading

This guide is for informational purposes only and does not constitute medical or legal advice. Coverage policies and assistance programs change frequently. Always verify current requirements with your insurance company, healthcare provider, and relevant assistance programs. For personalized help with Pennsylvania insurance appeals, contact the Pennsylvania Insurance Department Consumer Services at 1-877-881-6388.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.